Group One Trading’s ESSA Pharma EPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-216,800
Closed -$41.4K 8387
2025
Q3
$41.4K Sell
216,800
-24,400
-10% -$29.2K ﹤0.01% 6129
2025
Q2
$410K Buy
241,200
+236,300
+4,822% +$399K ﹤0.01% 3618
2025
Q1
$7.74K Sell
4,900
-36,300
-88% -$61.4K ﹤0.01% 6416
2024
Q4
$73.7K Buy
41,200
+37,200
+930% +$118K ﹤0.01% 4771
2024
Q3
$24.2K Sell
4,000
-800
-17% -$4.39K ﹤0.01% 5130
2024
Q2
$25.2K Buy
4,800
+4,000
+500% +$25.4K ﹤0.01% 5057
2024
Q1
$6.79K Buy
800
+200
+33% +$1.75K ﹤0.01% 6063
2023
Q4
$3.96K Buy
+600
New +$2.96K ﹤0.01% 6599
2023
Q3
Sell
-19,600
Closed -$52.9K 7797
2023
Q2
$52.9K Sell
19,600
-66,000
-77% -$194K ﹤0.01% 5224
2023
Q1
$254K Buy
+85,600
New +$251K ﹤0.01% 3445
2022
Q4
Sell
-400
Closed -$7K 7452
2022
Q3
$7K Buy
+400
New +$1.05K ﹤0.01% 6692

Group One Trading's EPIX Position: Q3 2025 in Review

Group One Trading sold out of ESSA Pharma (EPIX) in Q3 2025, closing a stake of 83,823 shares — an estimated $100K sold.

Group One Trading first reported a position in EPIX in Q4 2022 and held it in 8 quarters. The position peaked at $168K in Q3 2024. 32 funds tracked by Wall St. Rank hold EPIX as of Q3 2025.

  • Group One Trading reported no remaining ESSA Pharma position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 83,823 ESSA Pharma shares in Q3 2025, an estimated $100K.
  • Group One Trading first reported a position in ESSA Pharma in Q4 2022 and held it in 8 quarters.
  • Group One Trading's ESSA Pharma position peaked at $168K in Q3 2024.
  • 32 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.